These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

761 related articles for article (PubMed ID: 20844478)

  • 21. Evaluation of the efficacy of transcranial direct current stimulation in the treatment of cognitive symptomatology in the early stages of psychosis: study protocol for a double-blind randomized controlled trial.
    Rabanea-Souza T; Cirigola SMC; Noto C; Gomes JS; Azevedo CC; Gadelha A; Cordeiro Q; Dias ÁM; Lacerda ALT
    Trials; 2019 Apr; 20(1):199. PubMed ID: 30953544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abnormal neural integration related to cognition in schizophrenia.
    Dolan RJ; Fletcher PC; McKenna P; Friston KJ; Frith CD
    Acta Psychiatr Scand Suppl; 1999; 395():58-67. PubMed ID: 10225334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional and anatomical aspects of prefrontal pathology in schizophrenia.
    Goldman-Rakic PS; Selemon LD
    Schizophr Bull; 1997; 23(3):437-58. PubMed ID: 9327508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lateral and medial hypofrontality in first-episode schizophrenia: functional activity in a medication-naive state and effects of short-term atypical antipsychotic treatment.
    Snitz BE; MacDonald A; Cohen JD; Cho RY; Becker T; Carter CS
    Am J Psychiatry; 2005 Dec; 162(12):2322-9. PubMed ID: 16330597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Negative symptoms of schizophrenia: clinical characteristics, pathophysiological substrates, experimental models and prospects for improved treatment.
    Millan MJ; Fone K; Steckler T; Horan WP
    Eur Neuropsychopharmacol; 2014 May; 24(5):645-92. PubMed ID: 24820238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroimaging of cognitive disability in schizophrenia: search for a pathophysiological mechanism.
    Ragland JD; Yoon J; Minzenberg MJ; Carter CS
    Int Rev Psychiatry; 2007 Aug; 19(4):417-27. PubMed ID: 17671874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of gamma-aminobutyric acid-modulating drugs on working memory and brain function in patients with schizophrenia.
    Menzies L; Ooi C; Kamath S; Suckling J; McKenna P; Fletcher P; Bullmore E; Stephenson C
    Arch Gen Psychiatry; 2007 Feb; 64(2):156-67. PubMed ID: 17283283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aberrant Prefrontal-Thalamic-Cerebellar Circuit in Schizophrenia and Depression: Evidence From a Possible Causal Connectivity.
    Jiang Y; Duan M; Chen X; Zhang X; Gong J; Dong D; Li H; Yi Q; Wang S; Wang J; Luo C; Yao D
    Int J Neural Syst; 2019 Jun; 29(5):1850032. PubMed ID: 30149746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Memory and cognition in schizophrenia.
    Guo JY; Ragland JD; Carter CS
    Mol Psychiatry; 2019 May; 24(5):633-642. PubMed ID: 30242229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Schizophrenia and cognition: a neurodevelopmental approach].
    Da Fonseca D; Rosset D; Bat F; Campredon S; Rouviere N; Givaudan M; Fakra E; Azorin JM; Poinso F
    Encephale; 2011 Dec; 37 Suppl 2():S133-6. PubMed ID: 22212843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GABA neuron alterations, cortical circuit dysfunction and cognitive deficits in schizophrenia.
    Gonzalez-Burgos G; Fish KN; Lewis DA
    Neural Plast; 2011; 2011():723184. PubMed ID: 21904685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cognition and neuropathology in schizophrenia.
    Arnold SE
    Acta Psychiatr Scand Suppl; 1999; 395():41-50. PubMed ID: 10225332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Executive functioning component mechanisms and schizophrenia.
    Kerns JG; Nuechterlein KH; Braver TS; Barch DM
    Biol Psychiatry; 2008 Jul; 64(1):26-33. PubMed ID: 18549874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Interactive rTMS protocols in psychiatry].
    Micoulaud-Franchi JA; Richieri R; Lancon C; Vion-Dury J
    Encephale; 2013 Dec; 39(6):426-31. PubMed ID: 23810752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discrimination of schizophrenia auditory hallucinators by machine learning of resting-state functional MRI.
    Chyzhyk D; Graña M; Öngür D; Shinn AK
    Int J Neural Syst; 2015 May; 25(3):1550007. PubMed ID: 25753600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brain rhythms connect impaired inhibition to altered cognition in schizophrenia.
    Pittman-Polletta BR; Kocsis B; Vijayan S; Whittington MA; Kopell NJ
    Biol Psychiatry; 2015 Jun; 77(12):1020-30. PubMed ID: 25850619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cognitive neuroscience of memory function and dysfunction in schizophrenia.
    Ranganath C; Minzenberg MJ; Ragland JD
    Biol Psychiatry; 2008 Jul; 64(1):18-25. PubMed ID: 18495087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neural correlates of cognitive deficits across developmental phases of schizophrenia.
    Kelly S; Guimond S; Lyall A; Stone WS; Shenton ME; Keshavan M; Seidman LJ
    Neurobiol Dis; 2019 Nov; 131():104353. PubMed ID: 30582983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Towards a Unifying Cognitive, Neurophysiological, and Computational Neuroscience Account of Schizophrenia.
    Heinz A; Murray GK; Schlagenhauf F; Sterzer P; Grace AA; Waltz JA
    Schizophr Bull; 2019 Sep; 45(5):1092-1100. PubMed ID: 30388260
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional integration between the posterior hippocampus and prefrontal cortex is impaired in both first episode schizophrenia and the at risk mental state.
    Benetti S; Mechelli A; Picchioni M; Broome M; Williams S; McGuire P
    Brain; 2009 Sep; 132(Pt 9):2426-36. PubMed ID: 19420091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.